{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tildrakizumab",
          "name": "Tildrakizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_topical_corticosteroids",
          "name": "Topical corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_interleukin_17_inhibitors",
          "name": "Interleukin-17 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.53,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.55,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Acitretin",
              "pro": [
                "drug_acitretin"
              ],
              "con": [
                "n_adv_acitretin"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "显示 Acitretin 在靶向通路上的有效性，且与病理机制相关联"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.51,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Methotrexate",
              "pro": [
                "drug_methotrexate"
              ],
              "con": [
                "n_adv_methotrexate"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "显示 Methotrexate 能够作用于相关靶点"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.49,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.65,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Cyclosporine",
              "pro": [
                "drug_cyclosporine"
              ],
              "con": [
                "n_adv_cyclosporine"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "显示 Cyclosporine 在靶向通路上的有效性"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Infliximab",
              "pro": [
                "drug_infliximab"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "抗体疗法显示在相关靶点的作用"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.46,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.65,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Etanercept",
              "pro": [
                "drug_etanercept"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "显示 Etanercept 具有作用机制"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.65,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Adalimumab",
              "pro": [
                "drug_adalimumab"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "有效的生物药物显示出潜在作用"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.44,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Secukinumab",
              "pro": [
                "drug_secukinumab"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "靶向 IL-17 的治疗"
          ],
          "safety_risk": [
            "存在离靶作用的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.43,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.55,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Tildrakizumab",
              "pro": [
                "drug_tildrakizumab"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "IL-23 抑制剂在相关通路上的效果"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.55,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Ustekinumab",
              "pro": [
                "drug_ustekinumab"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "靶向免疫耐受的药物"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.4,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Topical corticosteroids",
              "pro": [
                "drug_topical_corticosteroids"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "局部治疗的常见选择"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.38,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Apremilast",
              "pro": [
                "drug_apremilast"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "小分子药物可能适合该病症"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.39,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.21,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.5
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse Effects of Interleukin-17 inhibitors",
              "pro": [
                "drug_interleukin_17_inhibitors"
              ],
              "con": [
                "n_adv_infliximab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "干扰 IL-17 信号的药物在相关通路上有前景"
          ],
          "safety_risk": [
            "存在离靶作用导致不良反应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H12",
      "H11"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg",
          "type": "Target",
          "label": "Target for Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pw",
          "type": "Pathway",
          "label": "Pathway for psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "Acitretin Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "Acitretin Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "Adverse Effects of Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "Methotrexate Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "Methotrexate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "Adverse Effects of Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclosporine",
          "type": "Target",
          "label": "Cyclosporine Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclosporine",
          "type": "Pathway",
          "label": "Cyclosporine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclosporine",
          "type": "Phenotype",
          "label": "Adverse Effects of Cyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "Infliximab Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "Infliximab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "Adverse Effects of Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用药物显示效果"
        },
        {
          "source": "n_tg",
          "target": "n_pw",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路层面关联"
        },
        {
          "source": "n_pw",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路通向已明确的病症"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "有效的免疫抑制药物"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用于严重病例"
        },
        {
          "source": "drug_infliximab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抗体疗法对皮肤病有效"
        },
        {
          "source": "drug_etanercept",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "肿瘤坏死因子抑制剂的有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有效的生物药物"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "靶向IL-17，适合千疮"
        },
        {
          "source": "drug_tildrakizumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "IL-23抑制剂，显示效果"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向免疫耐受，应用于多种类型"
        },
        {
          "source": "drug_topical_corticosteroids",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "局部治疗常见选择"
        },
        {
          "source": "drug_apremilast",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "小分子药物，可能适合"
        },
        {
          "source": "drug_interleukin_17_inhibitors",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "干扰IL-17信号，有前景"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_ot_cyclosporine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_cyclosporine",
          "target": "n_rp_cyclosporine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_cyclosporine",
          "target": "n_adv_cyclosporine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_cyclosporine",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "score": 0.53,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Acitretin 在靶向通路上显示出有效性",
          "尽管存在潜在不良反应风险，仍然可以作为治疗选择"
        ],
        "caveats": [
          "离靶作用导致的不良反应需进一步评估"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.51,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Methotrexate 在治疗中具有有效的免疫抑制作用",
          "潜在的离靶不良反应需注意"
        ],
        "caveats": [
          "需在医生监控下使用以避免严重不良反应"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "score": 0.49,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Cyclosporine 对于严重病例表现出有效性",
          "需要监测其引发的潜在不良反应"
        ],
        "caveats": [
          "长期使用需评估风险与益处"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug ➔ Target for Generalised pustular psoriasis ➔ Pathway for psoriasis ➔ Generalised pustular psoriasis",
          "reason": "Acitretin, Methotrexate, Cyclosporine 等药物均显示出针对靶点和相关通路的有效性。"
        }
      ],
      "remaining_gaps": [
        "离靶作用导致的不良反应的具体机制尚未完全阐明",
        "针对各药物不良反应的具体案例需要更多的实证支持"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "seed_x",
            "seed_y"
          ],
          "impact_summary": "补充了大部分靶向机制，为后续研究提供基础"
        },
        {
          "round": 2,
          "seeds": [
            "seed_a",
            "seed_b"
          ],
          "impact_summary": "临床效果符合预期，但潜在不良反应仍需警惕"
        }
      ],
      "lessons": [
        "重点关注药物的离靶作用及其引发的副作用",
        "持续更新和审视支持证据以加强治疗方案的有效性"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "需优先考虑对靶向疗法的实证支持，明确阐述不良反应机制"
      },
      {
        "role": "Skeptic",
        "patch": "对于每个候选药物，需详述潜在不良反应的机制和预防措施"
      }
    ],
    "heuristics": [
      {
        "when": "考虑生物药物",
        "then": "详细列举各药物的不良反应风险，特别针对免疫抑制药物"
      }
    ]
  }
}